GB2431108A - Applicator for dispensing cryogenic fluid - Google Patents

Applicator for dispensing cryogenic fluid Download PDF

Info

Publication number
GB2431108A
GB2431108A GB0518219A GB0518219A GB2431108A GB 2431108 A GB2431108 A GB 2431108A GB 0518219 A GB0518219 A GB 0518219A GB 0518219 A GB0518219 A GB 0518219A GB 2431108 A GB2431108 A GB 2431108A
Authority
GB
United Kingdom
Prior art keywords
applicator according
applicator
cup
inlet
exhaust
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB0518219A
Other versions
GB0518219D0 (en
Inventor
Mohammed Firoz Hussein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB0518219A priority Critical patent/GB2431108A/en
Publication of GB0518219D0 publication Critical patent/GB0518219D0/en
Priority to PCT/GB2006/003280 priority patent/WO2007028975A1/en
Publication of GB2431108A publication Critical patent/GB2431108A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/02Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques
    • A61B18/0218Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques with open-end cryogenic probe, e.g. for spraying fluid directly on tissue or via a tissue-contacting porous tip

Landscapes

  • Health & Medical Sciences (AREA)
  • Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Otolaryngology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)
  • Surgical Instruments (AREA)

Abstract

The apparatus comprises an applicator 10 for the dispensing of cryogenic fluid in the treatment of lesions in epidermal tissue, the applicator comprising a generally cup shaped element 12 with an inlet 13 and at least one exhaust aperture 14. The inlet and exhaust aperture may be formed in a single aperture in the cup (fig 7). The cup may be formed from clear plastics and have a double walled construction.

Description

IMPROVEMENTS IN OR RELATING TO CRYOGENIC
THERAPEUTIC TREATMENTS
Field of Invention
The present invention relates to cryogenic therapeutic treatments and, in particular provides an apparatus and device to facilitate in the application of cryogenic fluids for use in therapeutic treatments.
Background to the Invention
Cryosurgery is the destruction of tissues using the properties of freezing. The use of liquified gas coolants to cool and freeze tissue has long been known. The main agent used in medical treatment is liquid nitrogen. This is conveniently applied via the spraying of a cryogenic agent. Liquid nitrogen applied with a cotton bud is much less cold and less destructive. Commonly employed cryogenic fluids are liquid nitrogen and dimcthyl ether/propane aerosol (this formulation has previously been employed by a product known as Histofreezer TM). This achieves a skin temperature of between zero and - 50 C. It is well known to produce a cooling effect by the evaporation of a liquid. l-or example, dichiorotetrafluoroethane (also known as FrigidermTM or Freon 114) has been used extensively in cosmetic surgery to cool and stiffen skin. An advantage of dichlorotctrafluoroethane is that under normal conditions its maximum skin cooling temperature is -40 C, even though its boiling point is +3.80 C. Ethyl chloride is an efficient skin refrigerant but has the undesirable qualities of being explosive when mixed with air, toxic to the hvcr, as well as being capable of causing general anesthesia upon inhalation by the patient or doctor. * ***
* 1 It has been proven that colder cryorefrigerants (Cryosthesia -60 C also known as * * dichiorodifluoromethane or Freon 12, boiling point -29.8 C) can produce maximum skin cooling temperatures of -66 C, but care needs to be taken in the application, since improper * use can cause unwanted tissue damage and resulting in serious complications, such a scarring, depigmentation and infection. Unfortunately, all of these chlorofluorocarbon refrigerants have * PS, *, been shown to damage the ozone layer and their use is now strictly controlled if not banned in I.', many countries.
Dry ice or frozen carbon dioxide has also been used to cool the skin. However, applying dry ice to an epiderrnal surface can quickly produce temperatures of close to -7 8 C.
"Dry ice" application has been shown to be destructive to the epithelium layer and is now more commonly used to improve the penetration of skin peeling chemicals by removing the epidermis just prior to peel-acid application. Because temperatures of -78 C. are rapidly approached with little room for manual control, direct solid state, "dry ice" contact is not a viable option for controlled cooling of skin prior to or during dermabrasion if the surgeon is to mininuze thermal damage. Surgeons have reported that solid carbon dioxide contact produced scarring because it was applied under pressure that occluded the otherwise warming local blood supply.
Certain cryosurgery procedures are applied prior to mechanical dermabrasion. The hardness of the skin freeze has been shown to be critical in controlling the depth of dermabrasion and classified as either superficial (0.2-0.5 mm), moderate (0.5-1.0 mm), or deep (1.5-2.0 miTi) according to Ayres {Ayres S III: Superficial chemosurgery, including combined technique, using dermabrasion, in Epstein E, Epstein E Jr, editors: Skin surgery. Springfield, III., 1982, Charles C Thomas, Publisher.} The skin temperatures achieved and thus the hardness of the skin is dependent upon the type of freezing agent, skin temperature prior to treatment, operating room temperature and numerous other factors.
A recent and particularly valuable therapeutic use of cryogenics is to provide localized freezing of a part of a human or animal body in order to remove a wart or other growth from epidermal tissue. In this use, a refrigerant is maintained under pressure in a can and is dispensed, via a valve and an outlet tube, through a cotton wool bud which surrounds the discharge end of the outlet tube and which is placed on or near the site to be treated.
Handhcld, liquid nitrogen cryosurgical devices and other refrigerant devices have been used to : treat a wide range of common skin lesions. Conditions commonly treated in general practice S S are: Verruca (warts), Actinic Keratoses, Seborrheic Keratoses, Molluscum, Papilloma (skin * . : tags), Lentigines (age spots), Condyloma (genital warts), and Basal Cell Carcinoma (skin * . cancer).
* 30 EP057030 provides a hand-held device for the cryogenic treatment of a body, * comprising a container for a cryogenic fluid and an application end, the container being in the : form of an isothermal reservoir comprising at one of its ends a wide filler opening which can be sealed by a stopper while its other end has passing through it a channel or conduit for the flow of liquid, this other end being equipped with an adapted application nozzle, the sealing stopper of the reservoir being provided with a vent for the escape of the vaporised fraction of the coohng liquid and comprising, if appropriate, means for regulating the cross-section of this vent.
W02004042763 provides an applicator for an anti-microbial solution and includes an aerosol container and an applicator pad assembly having a hollow arm. The hollow arm has a proximal end attached to an aerosol cap and a distal end having a flanged arm plate to receive a foam applicator pad. The aerosol cap is removeably attached to the aerosol container. A solution flow control is in communication with the aerosol container for selectively dispensing the anti-microbial solution. The aerosol container holds the antimicrobial solution under pressure and flow is controlled by a pressure-sensitive flow control tab.
US6226996 provides a device that uniformly cools a surface to a specified temperature using a mist of cryogenic fluid. The device comprises a cryogenic fluid reservoir, a valve for controllably releasing the fluid through an atomizing nozzle, a non-contact temperature sensor, and a control unit to display the measured temperature. The control means can optionally pre-set the desired surface temperature and control the valve. The application of mist can be controlled. However, this device does not limit the area of application of the cryogenic fluid.
One device which has been used to assist the physician in providing localised refrigerant comprises an acrylic plate having frusto-conical apertures: the plate is placed upon a patients skin such that an aperture surrounds a lesion; the plate will typically have several apertures of varying sizes such that an appropriate amount of refrigerant can be placed upon a lesion without damaging skin surrounding a lesion. These plates arc typically employed with liquid nitrogen, since, in some cases, accurate dispensing of such fluid from an aerosol canister filled with refrigerant can be problematic. One such type of acrylic plate device is marketed by Brymill Cryogenic Systems having a trade name "Cryoplate".
* Whilst this type of device can assist in an improved localisation of refrigerant fluid and : protection of adjacent skin areas, it is a relatively expensive item and needs to be subjected a * . sterilisation treatment after each use; furthermore this type of plastics can be easily scratched, * 30 linuting the number of times that the device can be used: scratched and/or otherwise * : * ..: damaged plates do not inspire any patient confidence. A further disadvantage is that the plate, once placed upon a patient's skin may be susceptible to leakage of a refrigerant fluid since the edges of the frusto-conical opening may not be maintained in continuous circumferential IS.. * . S*S.
contact with the skin because of the contours of the body, patient movement and the fact that the lips of the frusto-conical aperture are coplanar with the underside of the planar acrylic member. Furthermore, the absence of a handle on a material having non-textured surface may lead to slippage in use. A still further problem is that the device needs to be held down manually, whereby the physician's hand or the hand of his assistant/the patient is susceptible to intimate contact with cryogenic fluid in the event of a spillage. This application has neither been used nor advocated with aerosol based cryogenic products.
Given the disadvantages of current human epidermal and mucosal epidermal skin cooling techniques, a need exists for a device that provides a safe and economical alternative.
Object of the Invention The present invention seeks to provide a solution to the problems addressed above.
The present invention seeks to provide an improved apparatus for the topical application of cryogenic substances in epidemiological, gynaecological and other histological treatments and the like.
Statement of Invention
In accordance with a first aspect of the invention, there is provided an applicator for the dispensing of cryogenic fluid in the treatment of lesions in epidermal tissue, the apphcator comprising a generally cup shaped element having side and base walls, the side wall defining a circumferential rim, the walls defining an inlet for a cryogenic fluid and a number of exhaust apertures to allow for the exhaust of evaporated cryogenic fluid from a treatment area about which the rim surrounds.
In use, the cup is held against the skin over the area to be treated. Cryogenic material is supplied via a tube from a cryogenic source such as an aerosol equipped with a valve to effect a controlled release of cryogenic gas. When the liquid gas is released it collects within the cup' thereby affecting only the portion of the skin contained within the cup' area.
: : : :* The inlet for the cryogenic fluid can be disposed within the base wall of the cup; ... 30 furthermore, the inlet can comprise a tube which extends inwardly from the wall. The inlet * : s can be centrally displaced. The inlet can be connected to an aerosol refrigerant by means of an intermediate tube.
as....
A simple exhaust may be provided, which could vent by means of a small diameter a integrally formed tube which can enable attachment with a flexible plastics exhaust tube, a...
whereby to prevent the release of exhaust gases from occluding vision for a physician during treatment..
Two or more exhaust apertures, may be provided, which can be distributed symmetrically about the inlet. Conveniently, the exhaust apertures have a diameter of between 1 and 3 nm-i. The exhaust gases can be guided through an exhaust tube. Conveniently, the exhaust tube extends in a generally parallel fashion with intermediate tube A handle can be provided, which enables the applicator to be correctly placed with a minimum of risk of injury to an operator of the applicator. Conveniently, the applicator is manufactured from a clear plastics material.
Preferably, the cup is of a double walled construction, whereby accidental contact by a physician does not cause distress or affect procedure. The rim can have a diameter of between 5 and 35 mm. The walls of the cup can extend between 4 - 20 mm in height, or more if desired/required by clinical need, from the rim towards the base.
An endoscope can also be provided with a viewing lens within the cup, such that a view of the lesion may be obtained during treatment, as appropriate when treating lesions within orifices such as cervical lesion, oral or anal. Superficial lesions of the skin are ordinarily easily visualised and monitored since the cups are conveniently made of a clear transparent plastic.
Conveniently, the source of cryogenic fluid comprises an aerosol canister of freezer spray.
To assist in the containment of cryogenic fluid, it may be convenient if a cup has a resilient foam or elastomeric plastics element arranged around a peripheral rim thereof.
Brief Description of the Figures
For a better understanding of the present invention, reference will now be made, by : * way of example only, to the Figures as shown in the accompanying drawing sheets, wherein:- * *** Figure 1 illustrate a first embodiment of the invention in perspective view; Figure 2 shows an example of a first embodiment in use; * : .* 30 Figures 3a and 3b show in detail a large size cup in accordance with the invention; * : * * * Figure 4a and 4b show in detail a medium size cup in accordance with the invention; Figure 5a and 5b show in detail a small size cup in accordance with the invention; Figure 6 shows a first alternative type of cup; I...
S "S.
Figure 7 shows a second alternative type of cup; Figures 8 and 8b show a third alternative type of cup; and, Figure 9 shows a fourth alternative type of cup.
Detailed description of the Preferred Embodiments
There will now be described, by way of example only, the best mode contemplated by the inventor for carrying out the present invention. In the following description, numerous specific details are set out in order to provide a complete understanding to the present invention. It will be apparent to those skilled in the art, that the present invention may be put into practice with variations of the specific With reference to Figure 1, there is shown a first embodiment of the invention, wherein an apparatus 10 comprises a cup element 12 which has an inlet 13 which receives a tube 16 for a supply of cryogenic fluid, for example from an aerosol canister 20 of cryogenic fluid. The inlet 13 can conveniently comprise a tube having a diameter corresponding to the inside diameter of the tube 16, to enable a push-fit connection. It is also possible to have a snap-fit connection configured. The inlet may extend for a few centimetres so that connection may be made with a supply tube outside of an internal cavity. Conveniently the canister of cryogenic fluid is an aerosol canister of "freezer spray", obtainable, for example, under the trade name Dermafreeze (Tivi).
An aerosol can, will have a valve through which the cryogen may be released. The valve is worked by manually depressing it using an actuator: Different types of actuator can be employed, depending on the particular technique being applied. It is preferable that the release of cryogenic fluid can be varied in a controlled fashion.
In Figure 1, the actuator has a female opening into which a clear, translucent or opaque plastic tube is inserted. The other end of a plastic tube functions as a female opening : * ** to allow the insertion on the cup. A clip mechanism may be employed to ensure a secure fit e...
* *** although an alternative method may be utilised for this purpose. The plastic tube will be S...
available in different sizes which may vary for example, to provide high levels of insulation or * : s 30 enable the flow rate to be increased.
* : . * * In use, with reference to Figure 2, the cup 12 will be held firmly against the epidermis * of the skin EP, the rim of the cup surrounding a lesion to be treated. As the actuator is * pressed the cryogen is released and it travels down the tube and is forced to make contact with S... * S S...
the skin as the cups do not permit it to escape. The effect of cryogen on the skin is to freeze it, in correspondence with the principles of thermodynamics. The dermis D will also be affected, to a certain extent, dependent upon the type of treatment being applied.
The cryogen is conveniently supplied by way of a cryogenic liquid retained within an aerosol can under pressure. As soon as it is released it rapidly expands to a gaseous state. In doing so it takes energy, in the form of heat, from the surrounding area. Therefore by taking the heat away from the skin it causes a cooling effect. The rapid nature of the expansion and the physical properties of the cryogen mean that it can cool to very low temperature and freeze down to -50 C. This effect can only be possible whilst the cryogen is in its liquid state.
Therefore if it takes longer to travel to the site of action the less likely it is to have a more profound effect.
There have been several prior art techniques that have been widely employed: Direct spraying of the cryogen to the skin - this technique has a moderate effect but requires copious amounts of cryogen to be sprayed to the area for the freezing to take effect and the spraying needs to be continued. One drawback is that the area being treated can only be controlled by the distance of the spray nozzle from the skin. So therefore the further back one is, the larger the target area and the closer one is the smaller the area. Nevertheless even when held closely, the spray disperses over a large area and has the potential risk on bouncing/splashing back off the skin and towards the user. The further away a spray nozzle is from a treatment area reduces the impact as the liquid has begun to expand or almost evaporated by the time it reaches the skin.
A further technique that has been employed is that of dripping a cryogen directly on the skin. By pressing the actuator of a spray element gently, the cryogen can be released at a slow rate and this has an effect of creating drips. Drips so produced can be allowed to fall on the skin but again there is a lack of control in the targeting of specific areas and also has the feature that the drip may evaporate or run/roll' away from the target area this potentially * *** freezing a healthy area. S...
Another technique is to allow drips of the cryogen to pass on an adhesive pad which S.., has been placed over the size and area of treatment. This improves on the direct dripping * :**. 30 technique. However it has drawbacks in that it may evaporate before hitting the adhesive pad : . and that which does saturate the adhesive pad must first freeze the pad, as it is made of a conductive material, before it has any effect of freezing the skin. Furthermore the area of ::: treatment is obscured and the extent of treatment and progress cannot be monitored. S...
A still further technique has been to employ a foam (or cotton wool) tipped applicator.
The cryogen is sprayed into the foam/bud until it starts to drip which indicates that it is saturated. The foam tip is then applied to the skin which allows the liquid to come into contact. This is an effective method but has two drawbacks. Onc is that the liquid will draw energy from the surrounding atmosphere and that the foam tip, which is made of a conductive material, has to be held very firmly, indenting the skin to allow sufficient contact area for an appreciable effect. Further the area of treatment is obscured.
In contrast, and in accordance with the invention, the use of cups enables a cryogen to make immediate contact with the skin and the cup is maintained in contact under some pressure which slows the rate of expansion of the cryogenic liquid, thereby increasing its effectiveness. The cup must be manufactured from a low thermal conductivity material, conveniently from a plastics material, whereby the cryogenic fluid is only able to draw energy from the skin as the cup is significantly less thermally conductive. The cup is also clear so the area of treatment is visible at all time as is the amount of cryogen sprayed onto the area. The diameter of the cup allows the user to choose the appropriate area of treatment. Furthermore the cup need only be held in position using light pressure so as not to allow leakage of liquid.
By the provision of vents, as the gas expands it can flow out of the enclosure defined between the cup and the skin vent.
With reference to Figures 3 - 5, the cups can be of various sizes to accommodate different sizes of lesions. Elliptical cups can also be employed. The diameters of the rims of the cups can vary from 50mm to 5mm, although there will be a greater requirement for 15, 10 & 5mm cups. The cups are conveniently made from polyformaldehyde, organic glass although other types of plastics materials such as acrylic plastics can be used, such the cups are clear / transparent so as to allow a user to visually monitor the extent and progress of treatment. In contrast other systems currently being used for similar purposes obscure the area of treatment during the treatment period.
: *. With reference to Figure 6, there is shown a cup 62, wherein the inlet tube 66 extends within the cup by a distance X to ensure that the fluid makes good initial contact with the lesion.
* 30 In addition to having specific vents as disclosed above, it would also be possible to * : have a valve which enables cryogenic fluids to pass into the cup through an inlet, which inlet * subsequently acts as an outlet after the cryogenic fluid supply ceases and the pressure within the cup due to the presence of evaporating cryogenic fluid causes the valve to enable such * S ** evaporating gaseous fluid to flow out. This has the advantage that only one aperture is required in the cup and thus the cup can be manufactured in a relatively simple manufacturing process. Alternatively, the cup may have single or multiple vent holes, as discussed above, which will allow immediate venting. The beneficial features described in relation to the single aperture cup are equally applicable, except that there is no initial build up of pressure. The rim of the cup may be fitted with a soft circumferential contact pad to assist in retention of cryogenic fluid without the need for significant pressure against the skin, once applied.
Other embodiments are shown in Figures 7, 8a and 8b. In Figure 7, a cup 70 is provided with a concentric inlet/outlet tube arrangement 60, 67. Figures 8a shows a sectional view through an embodiment 80 with a vent pipe 87 integrally formed with the cup, wherein the vent can be connected to a flexible plastics tube. By having a vent extension enables areas not previously as having been considered to be treated as being capable of being treated, since internal parts may be treated vent; To have a vented extension which in itself directs the venting away from a particular are or user or which may be used by attaching a flexible or other tube which takes the vent further away from the area of treatment. One particular advantage of this would be in the treatment of cervical warts (intravaginal lesions). Current systems do not allow a safe method of applying cryogen to this part of the female anatomy and the method just described would safely fulfil the objectives.
A further advantage provided by the present invention is that mucosal cpidermal tissue such as ENT tissue, anal tissue (in particular the perinium) and cervical tissue can be readily treated. The treatment of perinium, mucosal oral and cervical lesion has not been noted in previous aerosol cryogen product as their delivery mechanisms did not permit controlled treatments of these areas. In the treatment of internal tissues, the use of a cup with an elongate inlet, corresponding to a 1020cm portion of inlet tube may be indicated.
A still further advantage provided by the present invention arises with the treatment of warts, especially elongate warts including those commonly referred to as tag warts. Many : ** warts extend outwardly from the epidermis; previous treatments have resulted in cryogenic * -. fluids being applied to one side of the wart and the treatment is not effective. In contrast and in accordance with the present invention, the use of a fluid cryogen enables the fluid to * : . 30 surround the base, walls and tip of the wart, whereby removal of the wart is ensured and can * : * be accomplished in a straightforward fashion.
S * S * S.. S.. * S
* S S* Referring now to Figure 9, a handle 99 is shown attached to the cup 90. The Figure is shown in plan view, with an inlet 92 and an outlet 97. Specific advantages of having a handle are numerous, allowing increased control in delivery of a cryogenic fluid. * . * * S *SS*
S Se.. S. * * S * * a.
* S.... * . a. * S * a.. * . I...

Claims (16)

  1. CLAIMS: 1. An applicator for the dispensing of cryogenic fluid in the
    treatment of lesions in epidcrmal tissue, the applicator comprising a generally cup shaped element having side and base walls, the side wall defining a circumferential rim, the walls defining an inlet for a cryogenic fluid and a number of exhaust apertures to allow for the exhaust of evaporated cryogenic fluid from a treatment area about which the rim surrounds.
  2. 2. An applicator according to claim I wherein the inlet for the cryogenic fluid is disposed within the base wall of the cup.
  3. 3. An applicator according to claim br 2, wherein inlet comprises a tube which extends inwardly from the wall.
  4. 4. An applicator according to claim I, wherein there is a single aperture in the cup and the inlet has a valve associated therewith whereby inlet and exhaust gases can flow through the same aperture.
  5. 5. An applicator according to any one of claims 1- 4, wherein there is provided two or more exhaust apertures, which are distributed symmetrically about the inlet.
  6. 6. An applicator according to any one of claims I - 5 wherein the inlet is connected to an aerosol refrigerant by means of an intermediate tube.
  7. 7. An applicator according to any one of claims 1- 6 wherein there is provided a * handle which enables the applicator to be correctly placed with a minimum of risk of injury to **..
    * an operator of the applicator.
  8. S...
    * :*. 30 8. An applicator according to any one of claims 1- 7, wherein the applicator is * * manufactured from a clear plastics material. I' * S * *p* . $5**
  9. 9. An applicator according to any one of claims I - 8, wherein the exhaust apertures have a diameter of between I and 3 mm.
  10. 10. An applicator according to any one of claims I - 9, wherein the rim has a diameter of between 5 and 35 mm.
  11. 11. An applicator according to any one of claims 1- 10, wherein the walls of the cup extend 4 - 20 mm from the rim towards the base.
  12. 12. An applicator according to any one of claims I - 11, wherein the cup has a double walled construction.
  13. 13. An applicator according to any one of claims I - 12, wherein the exhaust gases are guided through an exhaust tube.
  14. 14. An applicator according to claim 13, wherein exhaust tube extends in a generally parallel fashion with intermediate tube.
  15. 15. An applicator according to any one of claims I - 14, wherein there is provided an endoscope.
  16. 16. An applicator according to any one of claims 1- 15, wherein there is provided a foam/elastomeric material about the circumferential rim of the cup.
    I * I I...
    I * I. p. * I a.
    I * . I a I
GB0518219A 2005-09-07 2005-09-07 Applicator for dispensing cryogenic fluid Withdrawn GB2431108A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0518219A GB2431108A (en) 2005-09-07 2005-09-07 Applicator for dispensing cryogenic fluid
PCT/GB2006/003280 WO2007028975A1 (en) 2005-09-07 2006-09-06 Improvements in or relating to cryogenic therapeutic treatments

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0518219A GB2431108A (en) 2005-09-07 2005-09-07 Applicator for dispensing cryogenic fluid

Publications (2)

Publication Number Publication Date
GB0518219D0 GB0518219D0 (en) 2005-10-19
GB2431108A true GB2431108A (en) 2007-04-18

Family

ID=35221025

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0518219A Withdrawn GB2431108A (en) 2005-09-07 2005-09-07 Applicator for dispensing cryogenic fluid

Country Status (2)

Country Link
GB (1) GB2431108A (en)
WO (1) WO2007028975A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102015205367A1 (en) * 2015-03-24 2016-09-29 Pharmpur Gmbh cryotip

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9132031B2 (en) 2006-09-26 2015-09-15 Zeltiq Aesthetics, Inc. Cooling device having a plurality of controllable cooling elements to provide a predetermined cooling profile
US20080077201A1 (en) 2006-09-26 2008-03-27 Juniper Medical, Inc. Cooling devices with flexible sensors
US8192474B2 (en) 2006-09-26 2012-06-05 Zeltiq Aesthetics, Inc. Tissue treatment methods
US20080287839A1 (en) 2007-05-18 2008-11-20 Juniper Medical, Inc. Method of enhanced removal of heat from subcutaneous lipid-rich cells and treatment apparatus having an actuator
US8523927B2 (en) 2007-07-13 2013-09-03 Zeltiq Aesthetics, Inc. System for treating lipid-rich regions
ES2693430T3 (en) 2007-08-21 2018-12-11 Zeltiq Aesthetics, Inc. Monitoring of cooling of lipid-rich subcutaneous cells, such as cooling of adipose tissue
US8672931B2 (en) 2008-08-18 2014-03-18 3JT Enterprises, LLC Cryosurgical device with metered dose
US8603073B2 (en) 2008-12-17 2013-12-10 Zeltiq Aesthetics, Inc. Systems and methods with interrupt/resume capabilities for treating subcutaneous lipid-rich cells
AU2010242785B2 (en) 2009-04-30 2014-03-06 Zeltiq Aesthetics, Inc. Device, system and method of removing heat from subcutaneous lipid-rich cells
EP2528560A1 (en) 2010-01-25 2012-12-05 Zeltiq Aesthetics, Inc. Home-use applicators for non-invasively removing heat from subcutaneous lipid-rich cells via phase change coolants, and associated devices, systems and methods
US8676338B2 (en) 2010-07-20 2014-03-18 Zeltiq Aesthetics, Inc. Combined modality treatment systems, methods and apparatus for body contouring applications
US10722395B2 (en) 2011-01-25 2020-07-28 Zeltiq Aesthetics, Inc. Devices, application systems and methods with localized heat flux zones for removing heat from subcutaneous lipid-rich cells
ITMI20122050A1 (en) 2012-11-30 2014-05-31 Sixtem Life S R L DISPENSER OF CRYOGENIC SUBSTANCES AND PROCEDURE FOR DELIVERING THE SAME
US9545523B2 (en) 2013-03-14 2017-01-17 Zeltiq Aesthetics, Inc. Multi-modality treatment systems, methods and apparatus for altering subcutaneous lipid-rich tissue
US9844460B2 (en) 2013-03-14 2017-12-19 Zeltiq Aesthetics, Inc. Treatment systems with fluid mixing systems and fluid-cooled applicators and methods of using the same
WO2015117026A2 (en) 2014-01-31 2015-08-06 Zeltiq Aesthetics, Inc. Treating systems and methods for treating cellulite and providing other treatments
US10675176B1 (en) 2014-03-19 2020-06-09 Zeltiq Aesthetics, Inc. Treatment systems, devices, and methods for cooling targeted tissue
USD777338S1 (en) 2014-03-20 2017-01-24 Zeltiq Aesthetics, Inc. Cryotherapy applicator for cooling tissue
US10952891B1 (en) 2014-05-13 2021-03-23 Zeltiq Aesthetics, Inc. Treatment systems with adjustable gap applicators and methods for cooling tissue
RU2564432C1 (en) * 2014-06-06 2015-09-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Алтайский государственный медицинский университет" Министерства здравоохранения Российской Федерации Method of treating oral proliferative verrucous leukoplakia
US10568759B2 (en) 2014-08-19 2020-02-25 Zeltiq Aesthetics, Inc. Treatment systems, small volume applicators, and methods for treating submental tissue
US10935174B2 (en) 2014-08-19 2021-03-02 Zeltiq Aesthetics, Inc. Stress relief couplings for cryotherapy apparatuses
US11154418B2 (en) 2015-10-19 2021-10-26 Zeltiq Aesthetics, Inc. Vascular treatment systems, cooling devices, and methods for cooling vascular structures
WO2017120538A1 (en) 2016-01-07 2017-07-13 Zeltiq Aesthetics, Inc. Temperature-dependent adhesion between applicator and skin during cooling of tissue
US10765552B2 (en) 2016-02-18 2020-09-08 Zeltiq Aesthetics, Inc. Cooling cup applicators with contoured heads and liner assemblies
US11382790B2 (en) 2016-05-10 2022-07-12 Zeltiq Aesthetics, Inc. Skin freezing systems for treating acne and skin conditions
US10682297B2 (en) 2016-05-10 2020-06-16 Zeltiq Aesthetics, Inc. Liposomes, emulsions, and methods for cryotherapy
US10555831B2 (en) 2016-05-10 2020-02-11 Zeltiq Aesthetics, Inc. Hydrogel substances and methods of cryotherapy
US11076879B2 (en) 2017-04-26 2021-08-03 Zeltiq Aesthetics, Inc. Shallow surface cryotherapy applicators and related technology
JP7031138B2 (en) * 2017-05-11 2022-03-08 株式会社リコー Decellularized tissue manufacturing method and decellularized tissue manufacturing equipment
AU2019315940A1 (en) 2018-07-31 2021-03-04 Zeltiq Aesthetics, Inc. Methods, devices, and systems for improving skin characteristics
EP3669803A1 (en) 2018-12-20 2020-06-24 Oystershell NV Pen for forming carbon dioxide tablets
BR112021021419A2 (en) * 2019-04-26 2021-12-21 Cryoconcepts Lp Cutting-edge focal treatment design and method for optimizing heat transfer through low-temperature fluids and gases

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3712306A (en) * 1971-11-09 1973-01-23 Brymill Corp Cryogenic application chamber and method
WO2004089234A1 (en) * 2003-04-08 2004-10-21 3Rd Angle (U.K.) Ltd. Portable cryotherapeutic apparatus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1163573A (en) * 1965-09-04 1969-09-10 Swallowfield Aerosols Ltd Improvements in medicament applicators
GB1413282A (en) * 1971-08-12 1975-11-12 Keeler Optical Products Ltd Cryo-surgical instruments
AU3963078A (en) * 1977-09-25 1980-03-13 Kurio Medikaru Kk Apparatus for refrigeration treatment
DE8713858U1 (en) * 1987-10-15 1988-01-14 Cadena Medical Laser Gmbh, 4800 Bielefeld, De
DE4404213A1 (en) * 1994-02-10 1995-08-17 Herbert Seus Gmbh & Co Kg Targetted cryotherapy with automatic regulation of min. temp. of skin
DE10230435A1 (en) * 2002-07-06 2004-01-22 Willi Bauer Device for removing a tick from a puncture site on the skin comprises devices for surrounding the tick with a freezable or hardenable liquid

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3712306A (en) * 1971-11-09 1973-01-23 Brymill Corp Cryogenic application chamber and method
WO2004089234A1 (en) * 2003-04-08 2004-10-21 3Rd Angle (U.K.) Ltd. Portable cryotherapeutic apparatus

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102015205367A1 (en) * 2015-03-24 2016-09-29 Pharmpur Gmbh cryotip

Also Published As

Publication number Publication date
GB0518219D0 (en) 2005-10-19
WO2007028975A1 (en) 2007-03-15

Similar Documents

Publication Publication Date Title
GB2431108A (en) Applicator for dispensing cryogenic fluid
EP0987989B1 (en) Apparatus for cryogenic spray ablation of gastrointestinal mucosa
US6226996B1 (en) Device for controlled cooling of a surface
EP2337515B1 (en) Cryosurgical device with metered dose
EP0584930B1 (en) Cryosurgical ablation
US20070005048A1 (en) Method and apparatus for cryogenically treating lesions on biological tissue
US7776032B2 (en) Device for improved visualization of operative sites during surgery
US4022215A (en) Cryosurgical system
EP1129670A1 (en) Cryoablation catheter for long lesion ablations
Das et al. Cooling devices in laser therapy
US20090192504A1 (en) Cryosurgery system having unintegrated delivery and visualization apparatus
US3534739A (en) Cryosurgical delivery and application of liquified gas coolant
Torre Alternate cryogens for cryosurgery
Wetmore Cryosurgery for common skin lesions. Treatment in family physicians' offices.
US20080119840A1 (en) Ridged Cryoprobe Tip
AU2011101126A4 (en) Cryoshield
US11439452B2 (en) Systems and methods to treat wounds
US20070149958A1 (en) Cryoprobe with exhaust heater
GB2434987A (en) Device for use in cryogenic therapeutic treatments
AU2011218730A1 (en) Cryoshield
RU37312U1 (en) CRYOGENIC DEVICE
Pasquali Cryosurgical techniques
Patel Application of Cryosurgery in Veterinary Science
EP3669803A1 (en) Pen for forming carbon dioxide tablets
Klipping et al. Low temperature skin treatment

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)